IMS HEALTH, INC.

Inactive Instrument

IMS Health, Inc. Stock

Stocks

US4499341083

Biotechnology & Medical Research

End-of-day quote NYSE Other stock markets
- ^USD	-

Press Releases: IMS Health, Inc.

10-02-22	IMS HEALTH USD : Standard & Poor's Announces Changes to U.S. Indices	PR
-1-11-29	Ims Health Inc. : IMS to Present at the Bear Stearns Healthcare Conference on September 11 at 7:10 a.m. and 2:30 p.m. ET	BU
-1-11-29	Ims Health Inc. : IMS to Present at the Thomas Weisel Partners Conference on September 6 at 3:15 p.m. EDT	BU
-1-11-29	Ims Health Inc. : IMS Health Names Kevin Knightly Senior VP, Business Line Management; Adel Al-Saleh Appointed President, Europe, Middle East and Africa	BU
-1-11-29	Ims Health Inc. : IMS Health Delivers 11 Percent Revenue and Operating Income Growth in Second Quarter	BU

More press releases

News in other languages: IMS Health, Inc.

16-08-25	'WiWo': GfK-Mehrheitseigner erwägen Verkauf
16-08-25	KORREKTUR/'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
16-08-25	'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
09-10-08	IMS HEALTH USD : IMS relève ses prévisions de ventes pharmaceutiques mondiales
-1-11-29	Ims Health Inc. : IMS Health prévoit une croissance de 5 à 6 pour cent du marché pharmaceutique mondial en 2007

Managers and Directors: IMS Health, Inc.

Manager	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	64	2016-09-30
Jon Resnick PSD	President	53	2019-06-30
James Berkshire COO	Chief Operating Officer	53	2017-06-30

Director	Title	Age	Since
Ari Bousbib CHM	Chairman	64	2016-09-30

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+0.99%	+0.35%	+4.91%	+16.06%	48.7B
	REVOLUTION MEDICINES, INC.	+3.71%	+6.75%	+459.45%	+557.32%	42.05B
	IQVIA HOLDINGS INC.	+2.70%	+0.38%	+34.49%	+10.04%	38.26B
	BEONE MEDICINES AG	+5.60%	+8.13%	+16.67%	+72.18%	37.5B
	CELLTRION, INC.	+2.21%	+4.89%	+17.24%	+51.64%	31.44B
	ASCENDIS PHARMA A/S	+2.23%	+1.73%	-	-	16.47B
	MEDPACE HOLDINGS, INC.	+0.97%	+2.14%	+37.25%	+128.28%	16.33B
	EUROFINS SCIENTIFIC SE	-0.11%	+1.75%	+8.05%	+18.47%	13.98B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.75%	+14.01%	+77.94%	+29.28%	12.68B
	Average	+2.12%	+3.27%	+82.00%	+110.41%	28.6B
	Weighted average by Cap.	+2.52%	+2.41%	+98.60%	+131.40%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

The best tools reserved for subscribers to boost the performance of your investments!